Filing Details

Accession Number:
0001127602-20-015857
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-07 20:49:14
Reporting Period:
2020-05-05
Accepted Time:
2020-05-07 20:49:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
318154 Amgen Inc AMGN Biological Products, (No Disgnostic Substances) (2836) 953540776
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1375347 Sanders R Williams One Amgen Center Drive
Thousand Oaks CA 91320
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-05-05 846 $0.00 5,834 No 4 A Direct
Common Stock Disposition 2020-05-06 425 $237.31 5,409 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.
  2. The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1.